These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25201055)

  • 1. Predictors of and barriers to service use for children at risk of ADHD: longitudinal study.
    Sayal K; Mills J; White K; Merrell C; Tymms P
    Eur Child Adolesc Psychiatry; 2015 May; 24(5):545-52. PubMed ID: 25201055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of early school-based screening and intervention programs for ADHD on children's outcomes and access to services: follow-up of a school-based trial at age 10 years.
    Sayal K; Owen V; White K; Merrell C; Tymms P; Taylor E
    Arch Pediatr Adolesc Med; 2010 May; 164(5):462-9. PubMed ID: 20439798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and cost-effectiveness of a brief school-based group programme for parents of children at risk of ADHD: a cluster randomised controlled trial.
    Sayal K; Taylor JA; Valentine A; Guo B; Sampson CJ; Sellman E; James M; Hollis C; Daley D
    Child Care Health Dev; 2016 Jul; 42(4):521-33. PubMed ID: 27272608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protocol investigating the clinical utility of an objective measure of attention, impulsivity and activity (QbTest) for optimising medication management in children and young people with ADHD 'QbTest Utility for Optimising Treatment in ADHD' (QUOTA): a feasibility randomised controlled trial.
    Hall CL; James M; Brown S; Martin JL; Brown N; Selby K; Clarke J; Vijayan H; Guo B; Sayal K; Hollis C; Groom MJ
    BMJ Open; 2018 Feb; 8(2):e021104. PubMed ID: 29453304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex differences in predicting ADHD clinical diagnosis and pharmacological treatment.
    Mowlem FD; Rosenqvist MA; Martin J; Lichtenstein P; Asherson P; Larsson H
    Eur Child Adolesc Psychiatry; 2019 Apr; 28(4):481-489. PubMed ID: 30097723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and Predictors of Medication Use in Children with Attention-Deficit/Hyperactivity Disorder: Evidence from a Community-Based Longitudinal Study.
    Efron D; Gulenc A; Sciberras E; Ukoumunne OC; Hazell P; Anderson V; Silk TJ; Nicholson JM
    J Child Adolesc Psychopharmacol; 2019 Feb; 29(1):50-57. PubMed ID: 30508385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Preschool Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS) 6-year follow-up.
    Riddle MA; Yershova K; Lazzaretto D; Paykina N; Yenokyan G; Greenhill L; Abikoff H; Vitiello B; Wigal T; McCracken JT; Kollins SH; Murray DW; Wigal S; Kastelic E; McGough JJ; dosReis S; Bauzó-Rosario A; Stehli A; Posner K
    J Am Acad Child Adolesc Psychiatry; 2013 Mar; 52(3):264-278.e2. PubMed ID: 23452683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of health and school-based services in Australia by young people with attention-deficit/hyperactivity disorder.
    Sawyer MG; Rey JM; Arney FM; Whitham JN; Clark JJ; Baghurst PA
    J Am Acad Child Adolesc Psychiatry; 2004 Nov; 43(11):1355-63. PubMed ID: 15502594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reliable ratings or reading tea leaves: can parent, teacher, and clinician behavioral ratings of preschoolers predict ADHD at age six?
    O'Neill S; Schneiderman RL; Rajendran K; Marks DJ; Halperin JM
    J Abnorm Child Psychol; 2014 May; 42(4):623-34. PubMed ID: 24085388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in recognition of and service use for attention-deficit hyperactivity disorder in Britain, 1999-2004.
    Sayal K; Ford T; Goodman R
    Psychiatr Serv; 2010 Aug; 61(8):803-10. PubMed ID: 20675839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of a behavioural sleep intervention on symptoms and sleep in children with attention deficit hyperactivity disorder, and parental mental health: randomised controlled trial.
    Hiscock H; Sciberras E; Mensah F; Gerner B; Efron D; Khano S; Oberklaid F
    BMJ; 2015 Jan; 350():h68. PubMed ID: 25646809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults.
    Castells X; Blanco-Silvente L; Cunill R
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD007813. PubMed ID: 30091808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of a telehealth service delivery model for treating attention-deficit/hyperactivity disorder: a community-based randomized controlled trial.
    Myers K; Vander Stoep A; Zhou C; McCarty CA; Katon W
    J Am Acad Child Adolesc Psychiatry; 2015 Apr; 54(4):263-74. PubMed ID: 25791143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder.
    Stein MA; Sarampote CS; Waldman ID; Robb AS; Conlon C; Pearl PL; Black DO; Seymour KE; Newcorn JH
    Pediatrics; 2003 Nov; 112(5):e404. PubMed ID: 14595084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodal treatment in children and adolescents with attention-deficit/hyperactivity disorder: a 6-month follow-up.
    Duric NS; Assmus J; Gundersen D; Duric Golos A; Elgen IB
    Nord J Psychiatry; 2017 Jul; 71(5):386-394. PubMed ID: 28345387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
    Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effects of Long-Acting Stimulant and Nonstimulant Medications in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Meta-Analysis of Randomized Controlled Trials.
    Cerrillo-Urbina AJ; García-Hermoso A; Pardo-Guijarro MJ; Sánchez-López M; Santos-Gómez JL; Martínez-Vizcaíno V
    J Child Adolesc Psychopharmacol; 2018 Oct; 28(8):494-507. PubMed ID: 29897263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulant treatment for children: a community perspective.
    Angold A; Erkanli A; Egger HL; Costello EJ
    J Am Acad Child Adolesc Psychiatry; 2000 Aug; 39(8):975-84; discussion 984-94. PubMed ID: 10939226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.